| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.8 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |